Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Research article

Oxidative stress in hepatitis C infected end-stage renal disease subjects

Authors: Mehmet Horoz, Cengiz Bolukbas, Filiz F Bolukbas, Mehmet Aslan, Ahmet O Koylu, Sahbettin Selek, Ozcan Erel

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

Both uremia and hepatitis C infection is associated with increased oxidative stress. In the present study, we aimed to find out whether hepatitis C infection has any impact on oxidative stress in hemodialysis subjects.

Methods

Sixteen hepatitis C (+) hemodialysis subjects, 24 hepatitis C negative hemodialysis subjects and 24 healthy subjects were included. Total antioxidant capacity, total peroxide level and oxidative stress index were determined in all subjects.

Results

Total antioxidant capacity was significantly higher in controls than hemodialysis subjects with or without hepatitis C infection (all p < 0.05/3), while total peroxide level and oxidative stress index were significantly lower (all p < 0.05/3). Hepatitis C (-) hemodialysis subjects had higher total antioxidant capacity compared to hepatitis C (+) hemodialysis subjects (all p < 0.05/3). Total peroxide level and oxidative stress index was comparable between hemodialysis subjects with or without hepatitis C infection (p > 0.05/3).

Conclusion

Oxidative stress is increased in both hepatitis C (+) and hepatitis C (-) hemodialysis subjects. However, hepatitis C infection seems to not cause any additional increase in oxidative stress in hemodialysis subjects and it may be partly due to protective effect of dialysis treatment on hepatitis C infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. 1999, London: Oxford Science Publications, 3 Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. 1999, London: Oxford Science Publications, 3
2.
go back to reference Baliga R, Ueda N, Walker PD, Shah SV: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999, 31: 971-997. 10.1081/DMR-100101947.CrossRefPubMed Baliga R, Ueda N, Walker PD, Shah SV: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999, 31: 971-997. 10.1081/DMR-100101947.CrossRefPubMed
3.
go back to reference Descamps-Latscha B, Witko-Sarsat V: Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl. 2001, 78: 108-113. 10.1046/j.1523-1755.2001.07841.x.CrossRef Descamps-Latscha B, Witko-Sarsat V: Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl. 2001, 78: 108-113. 10.1046/j.1523-1755.2001.07841.x.CrossRef
4.
go back to reference Himmelfarb J, McMonagle E, McMenamin E: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 2000, 58: 2571-2578. 10.1046/j.1523-1755.2000.00443.x.CrossRefPubMed Himmelfarb J, McMonagle E, McMenamin E: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 2000, 58: 2571-2578. 10.1046/j.1523-1755.2000.00443.x.CrossRefPubMed
5.
go back to reference Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?. Kidney Int. 1998, 54: 1290-1295. 10.1046/j.1523-1755.1998.00093.x.CrossRefPubMed Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?. Kidney Int. 1998, 54: 1290-1295. 10.1046/j.1523-1755.1998.00093.x.CrossRefPubMed
6.
go back to reference Zoccali C, Mallamaci F, Tripepi G: AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant. 2000, 15: 7-11. 10.1093/ndt/15.suppl_1.7.CrossRefPubMed Zoccali C, Mallamaci F, Tripepi G: AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant. 2000, 15: 7-11. 10.1093/ndt/15.suppl_1.7.CrossRefPubMed
7.
go back to reference Miyata T, Sugiyama S, Saito A, Kurokawa K: Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int. 2001, 59: 25-31. 10.1046/j.1523-1755.2001.07833.x.CrossRef Miyata T, Sugiyama S, Saito A, Kurokawa K: Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int. 2001, 59: 25-31. 10.1046/j.1523-1755.2001.07833.x.CrossRef
8.
go back to reference Ichikawa I, Kiyama S, Yoshioka T: Renal antioxidant enzymes: their regulation and function. Kidney Int. 1994, 45: 1-9.CrossRefPubMed Ichikawa I, Kiyama S, Yoshioka T: Renal antioxidant enzymes: their regulation and function. Kidney Int. 1994, 45: 1-9.CrossRefPubMed
9.
go back to reference Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49: 1304-1313.CrossRefPubMed Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49: 1304-1313.CrossRefPubMed
10.
go back to reference Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism. 1992, 41: 1229-1232. 10.1016/0026-0495(92)90014-2.CrossRefPubMed Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism. 1992, 41: 1229-1232. 10.1016/0026-0495(92)90014-2.CrossRefPubMed
11.
go back to reference Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol. 1998, 9: 457-463.PubMed Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol. 1998, 9: 457-463.PubMed
12.
go back to reference Fabrizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, Pagano A, Erba G, Locatelli F: Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. Nephrol Dial Transplant. 1997, 12: 298-303. 10.1093/ndt/12.2.298.CrossRefPubMed Fabrizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, Pagano A, Erba G, Locatelli F: Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. Nephrol Dial Transplant. 1997, 12: 298-303. 10.1093/ndt/12.2.298.CrossRefPubMed
13.
go back to reference Fabrizi F, Bunnapradist S, Lunghi G, Aucella F, Martin P: Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Minevra Urol Nephrol. 2004, 56: 249-257. Fabrizi F, Bunnapradist S, Lunghi G, Aucella F, Martin P: Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Minevra Urol Nephrol. 2004, 56: 249-257.
14.
go back to reference Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 1995, 22: 449-456. 10.1016/0168-8278(95)80108-1.CrossRefPubMed Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 1995, 22: 449-456. 10.1016/0168-8278(95)80108-1.CrossRefPubMed
15.
go back to reference De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, Floyd RA: Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med. 1996, 21: 291-5. 10.1016/0891-5849(96)00044-5.CrossRefPubMed De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, Floyd RA: Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med. 1996, 21: 291-5. 10.1016/0891-5849(96)00044-5.CrossRefPubMed
16.
go back to reference Koken T, Serteser M, Kahraman A, Gokce C: Oxidative stress markers in hepatitis C infected hemodialysis patients. J Nephrol. 2002, 15: 302-307.PubMed Koken T, Serteser M, Kahraman A, Gokce C: Oxidative stress markers in hepatitis C infected hemodialysis patients. J Nephrol. 2002, 15: 302-307.PubMed
17.
go back to reference Nascimento MM, Suliman ME, Bruchfeld A, Hayashi SY, Manfro RC, Qureshi AR, Pecoits-Filho R, Pachaly MA, Renner L, Stenvinkel P, Riella MC, Lindholm B: The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. Nephrol Dial Transplant. 2004, 19: 3112-3116. 10.1093/ndt/gfh508.CrossRefPubMed Nascimento MM, Suliman ME, Bruchfeld A, Hayashi SY, Manfro RC, Qureshi AR, Pecoits-Filho R, Pachaly MA, Renner L, Stenvinkel P, Riella MC, Lindholm B: The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. Nephrol Dial Transplant. 2004, 19: 3112-3116. 10.1093/ndt/gfh508.CrossRefPubMed
18.
go back to reference Kato A, Odamaki M, Nakamura H, Yodoi J, Hishida A: Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection. Kidney Int. 2003, 63: 2262-2268. 10.1046/j.1523-1755.2003.t01-3-00002.x.CrossRefPubMed Kato A, Odamaki M, Nakamura H, Yodoi J, Hishida A: Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection. Kidney Int. 2003, 63: 2262-2268. 10.1046/j.1523-1755.2003.t01-3-00002.x.CrossRefPubMed
19.
go back to reference Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004, 37: 112-119. 10.1016/j.clinbiochem.2003.10.014.CrossRefPubMed Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004, 37: 112-119. 10.1016/j.clinbiochem.2003.10.014.CrossRefPubMed
20.
go back to reference Harma M, Harma M, Erel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003, 133: 563-566.PubMed Harma M, Harma M, Erel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003, 133: 563-566.PubMed
21.
go back to reference Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005, 38: 1103-1111. 10.1016/j.clinbiochem.2005.08.008.CrossRefPubMed Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005, 38: 1103-1111. 10.1016/j.clinbiochem.2005.08.008.CrossRefPubMed
22.
go back to reference Cao G, Prior RL: Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998, 44: 1309-1315.PubMed Cao G, Prior RL: Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998, 44: 1309-1315.PubMed
23.
go back to reference Miyazawa T: Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med. 1989, 7: 209-217. 10.1016/0891-5849(89)90017-8.CrossRefPubMed Miyazawa T: Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med. 1989, 7: 209-217. 10.1016/0891-5849(89)90017-8.CrossRefPubMed
24.
go back to reference Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon N, Jacquot C, Herbelin A, Kazatchkine M: Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron. 1991, 59: 279-285.CrossRefPubMed Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon N, Jacquot C, Herbelin A, Kazatchkine M: Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron. 1991, 59: 279-285.CrossRefPubMed
25.
go back to reference Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamin A, E and iron status. Free Radic Biol Med. 1994, 16: 339-3. 10.1016/0891-5849(94)90035-3.CrossRefPubMed Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamin A, E and iron status. Free Radic Biol Med. 1994, 16: 339-3. 10.1016/0891-5849(94)90035-3.CrossRefPubMed
26.
go back to reference Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997, 51: 1170-1181.CrossRefPubMed Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997, 51: 1170-1181.CrossRefPubMed
27.
go back to reference Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, Warnes TW: Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol. 2002, 36: 805-811. 10.1016/S0168-8278(02)00060-0.CrossRefPubMed Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, Warnes TW: Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol. 2002, 36: 805-811. 10.1016/S0168-8278(02)00060-0.CrossRefPubMed
28.
go back to reference Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ: The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta. 1987, 924: 408-419.CrossRefPubMed Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ: The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta. 1987, 924: 408-419.CrossRefPubMed
29.
go back to reference Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G: Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron. 1998, 80: 428-433. 10.1159/000045215.CrossRefPubMed Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G: Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron. 1998, 80: 428-433. 10.1159/000045215.CrossRefPubMed
30.
go back to reference Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis. 1998, 32: 629-634.CrossRefPubMed Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis. 1998, 32: 629-634.CrossRefPubMed
31.
go back to reference Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000, 11: 1896-1902.PubMed Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000, 11: 1896-1902.PubMed
32.
go back to reference Zevin D, Malachi T, Gafter U, Friedman J, Levi J: Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab. 1991, 17: 303-306.PubMed Zevin D, Malachi T, Gafter U, Friedman J, Levi J: Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab. 1991, 17: 303-306.PubMed
33.
go back to reference Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000, 11: 1896-1902.PubMed Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol. 2000, 11: 1896-1902.PubMed
34.
go back to reference Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993, 328: 1797-1801. 10.1056/NEJM199306243282501.CrossRefPubMed Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993, 328: 1797-1801. 10.1056/NEJM199306243282501.CrossRefPubMed
35.
go back to reference Tokita H, Fukui H, Tanaka A, Kamitsukasa H, Yagura M, Harada H, Okamoto H: Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol. 2005, 20: 752-758. 10.1111/j.1440-1746.2005.03800.x.CrossRefPubMed Tokita H, Fukui H, Tanaka A, Kamitsukasa H, Yagura M, Harada H, Okamoto H: Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol. 2005, 20: 752-758. 10.1111/j.1440-1746.2005.03800.x.CrossRefPubMed
36.
go back to reference Leone N, Rizzetto M: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2005, 51: 31-46.PubMed Leone N, Rizzetto M: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2005, 51: 31-46.PubMed
37.
go back to reference Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G: Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis. 2000, 35: 122-129.CrossRefPubMed Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G: Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis. 2000, 35: 122-129.CrossRefPubMed
38.
go back to reference Martin J, de Sequera P, Quiroga JA, Rico M, Fernandez M, Arocena C, Caramelo C, Carreno V: Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine. 2000, 12: 1248-1252. 10.1006/cyto.2000.0701.CrossRefPubMed Martin J, de Sequera P, Quiroga JA, Rico M, Fernandez M, Arocena C, Caramelo C, Carreno V: Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine. 2000, 12: 1248-1252. 10.1006/cyto.2000.0701.CrossRefPubMed
Metadata
Title
Oxidative stress in hepatitis C infected end-stage renal disease subjects
Authors
Mehmet Horoz
Cengiz Bolukbas
Filiz F Bolukbas
Mehmet Aslan
Ahmet O Koylu
Sahbettin Selek
Ozcan Erel
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-114

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.